ProfileGDS4718 / 202291_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 89% 97% 70% 86% 41% 59% 85% 93% 85% 80% 81% 53% 56% 49% 85% 92% 66% 49% 87% 86% 90% 80% 90% 78% 61% 92% 62% 89% 22% 29% 83% 83% 49% 86% 81% 35% 95% 78% 97% 89% 43% 92% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.564277
GSM549102patient 115, normal, homogenized [OPG study]9.0412289
GSM549104patient 119, normal, homogenized [OPG study]10.936297
GSM549108patient 138, normal, homogenized [OPG study]6.8520970
GSM549119patient 077, normal, homogenized [OPG study]8.5649586
GSM549133patient 032, cancer, homogenized [OPG study]4.9797441
GSM549139patient 042, cancer, homogenized [OPG study]6.0735859
GSM549099patient 107, normal, homogenized [OPG study]8.379885
GSM549109patient 139, normal, homogenized [OPG study]9.7238993
GSM549110patient 046, normal, homogenized [OPG study]8.5221585
GSM549114patient 063, normal, homogenized [OPG study]7.8879680
GSM549122patient 082, normal, homogenized [OPG study]8.0000581
GSM549134patient 033, cancer, homogenized [OPG study]5.6640853
GSM549136patient 036, cancer, homogenized [OPG study]5.8606656
GSM549140patient 044, cancer, homogenized [OPG study]5.425249
GSM549111patient 047, normal, homogenized [OPG study]8.5292485
GSM549113patient 057, normal, homogenized [OPG study]9.8161892
GSM549132patient 031, cancer, homogenized [OPG study]6.5870766
GSM549137patient 038, cancer, homogenized [OPG study]5.4512849
GSM549142patient 047, cancer, homogenized [OPG study]8.2905287
GSM549100patient 110, normal, homogenized [OPG study]8.5305386
GSM549107patient 135, normal, homogenized [OPG study]9.2327790
GSM549115patient 068, normal, homogenized [OPG study]7.9965680
GSM549116patient 072, normal, homogenized [OPG study]9.2420890
GSM549120patient 078, normal, homogenized [OPG study]7.6514778
GSM549131patient 030, cancer, homogenized [OPG study]6.1435661
GSM549118patient 074, normal, homogenized [OPG study]9.6780392
GSM549129patient 027, cancer, homogenized [OPG study]6.2833662
GSM549123patient 088, normal, homogenized [OPG study]9.0326489
GSM549124patient 006, cancer, homogenized [OPG study]4.2587822
GSM549126patient 015, cancer, homogenized [OPG study]4.4809829
GSM549128patient 025, cancer, homogenized [OPG study]8.2410383
GSM549103patient 117, normal, homogenized [OPG study]8.0079983
GSM549117patient 073, normal, homogenized [OPG study]5.437549
GSM549138patient 041, cancer, homogenized [OPG study]8.5676986
GSM549141patient 045, cancer, homogenized [OPG study]8.1351281
GSM549130patient 028, cancer, homogenized [OPG study]4.7901235
GSM549101patient 111, normal, homogenized [OPG study]10.239995
GSM549105patient 128, normal, homogenized [OPG study]7.5562178
GSM549106patient 134, normal, homogenized [OPG study]11.26197
GSM549112patient 048, normal, homogenized [OPG study]9.0696989
GSM549125patient 011, cancer, homogenized [OPG study]5.1590543
GSM549127patient 024, cancer, homogenized [OPG study]9.4285292
GSM549135patient 035, cancer, homogenized [OPG study]6.2932662